Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.14 USD
Change Today +0.0135 / 10.59%
Volume 116.1K
ILIU On Other Exchanges
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kenneth S. Kornman D.D.S., PH.D.

Founder, President, Chief Scientific Officer and Director, Interleukin Genetics, Inc.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Kenneth S. Kornman, also known as Ken, D.D.S., PH.D. founded Interleukin Genetics, Inc in 1986 and serves as its the President and Chief Scientific Officer. Dr. Kornman served as Chief Executive Officer of Interleukin Genetics, Inc since August 23, 2012 and served as its Secretary. Dr. Kornman has also been a Consultant and scientific researcher for many major oral care and pharmaceutical companies. Dr. Kornman served as Chief Executive Officer of Interleukin Genetics ...

Read Full Background

Corporate Headquarters*

135 Beaver Street
Waltham, Massachusetts 02452

United States

Phone: 781-398-0700
Fax: 781-398-0720

Board Members Memberships*

Founder, President, Chief Scientific Officer and Director


Emory University
University of Michigan
University of Michigan
Duke University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$401,400

Stock Options*

All Other Compensation$3,296
Exercisable Options1,077,125
Unexercisable Options1,702,875
Total Number of Options2,780,000

Total Compensation*

Total Annual Cash Compensation$404,696
Total Short Term Compensation$401,400
Other Long Term Compensation$3,296
Total Calculated Compensation$932,496
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILIU:US $0.14 USD +0.0135


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERLEUKIN GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at